Multimodality 3D image fusion with live fluoroscopy reduces radiation dose during catheterization of congenital heart defects

Dimitri Buytaert,Kristof Vandekerckhove,Joseph Panzer,Laurence Campens,Klaus Bacher,Daniël De Wolf

DOI: https://doi.org/10.3389/fcvm.2023.1292039

IF: 3.6

2024-01-12

Frontiers in Cardiovascular Medicine

Abstract:Introduction: Imaging fusion technology is promising as it is radiation and contrast sparing. Herein, we compare conventional biplane angiography to multimodality image fusion with live fluoroscopy using two-dimensional (2D)–three-dimensional (3D) registration (MMIF 2D−3D ) and assess MMIF 2D−3D impact on radiation exposure and contrast volume during cardiac catheterization of patients with congenital heart disease (CHD). Methods: We matched institutional MMIF 2D−3D procedures and controls according to patient characteristics (body mass index, age, and gender) and the seven procedure-type subgroups. Then, we matched the number of tests and controls per subgroup using chronological ordering or propensity score matching. Subsequently, we combined the matched subgroups into larger subgroups of similar procedure type, keeping subgroups with at least 10 test and 10 control cases. Air kerma (AK) and dose area product (DAP) were normalized by body weight (BW), product of body weight and fluoroscopy time (BW × FT), or product of body weight and number of frames (BW × FR), and stratified by acquisition plane and irradiation event type (fluoroscopy or acquisition). Three senior interventionists evaluated the relevance of MMIF 2D−3D (5-point Likert scale). Results: The Overall group consisted of 54 MMIF 2D−3D cases. The combined and matched subgroups were pulmonary artery stenting (Stent PUL ), aorta angioplasty (Plasty AO ), pulmonary artery angioplasty (Plasty PUL ), or a combination of the latter two (Plasty). The FT of the lateral plane reduced significantly by 69.6% for the Overall MMIF 2D−3D population. AK BW and DAP BW decreased, respectively, by 43.9% and 39.3% (Overall group), 49.3% and 54.9% (Plasty AO ), and 36.7% and 44.4% for the Plasty subgroup. All the aforementioned reductions were statistically significant except for DAP BW in the Overall and Plasty (sub)groups. The decrease of AK BW and DAP BW in the Stent PUL and Plasty PUL subgroups was not statistically significant. The decrease in the median values of the weight-normalized contrast volume (CMC BW ) in all five subgroups was not significant. Cardiologists considered MMIF 2D−3D very useful with a median score of 4. Conclusion: In our institution, MMIF 2D−3D overall enabled significant AK BW reduction during the catheterization of CHD patients and was mainly driven by reduced FT in the lateral plane. We observed significant AK BW reduction in the Plasty and Plasty AO subgroups and DAP BW reduction in the Plasty AO subgroup. However, the decrease in CMC BW was not significant.

cardiac & cardiovascular systems